BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee MF, Pan MH, Chiou YS, Cheng AC, Huang H. Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. J Agric Food Chem 2011;59:11853-61. [PMID: 21942447 DOI: 10.1021/jf202426k] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Siddiqui A, Dandawate P, Rub R, Padhye S, Aphale S, Moghe A, Jagyasi A, Venkateswara Swamy K, Singh B, Chatterjee A, Ronghe A, Bhat HK. Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines. Bioorg Med Chem Lett 2013;23:635-40. [PMID: 23273518 DOI: 10.1016/j.bmcl.2012.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
2 Zhang Y, Shang Z, Gao C, Du M, Xu S, Song H, Liu T. Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. AAPS PharmSciTech 2014;15:1000-8. [PMID: 24831090 DOI: 10.1208/s12249-014-0129-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
3 Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des. 2013;19:6064-6093. [PMID: 23448440 DOI: 10.2174/13816128113199990407] [Cited by in Crossref: 273] [Cited by in F6Publishing: 247] [Article Influence: 34.1] [Reference Citation Analysis]
4 Lin C, Hsiao W, Wright DE, Hsu C, Lo Y, Wang Hsu G, Kao C. Resveratrol activates the histone H2B ubiquitin ligase, RNF20, in MDA-MB-231 breast cancer cells. Journal of Functional Foods 2013;5:790-800. [DOI: 10.1016/j.jff.2013.01.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Sinha D, Sarkar N, Biswas J, Bishayee A. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Semin Cancer Biol 2016;40-41:209-32. [PMID: 26774195 DOI: 10.1016/j.semcancer.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 17.7] [Reference Citation Analysis]
6 Fan C, Kong F, Shetti D, Zhang B, Yang Y, Wei K. Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer. Biochem Biophys Res Commun 2019;519:378-84. [PMID: 31519327 DOI: 10.1016/j.bbrc.2019.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Chan CM, Chang HH, Wang VC, Huang CL, Hung CF. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways. PLoS One 2013;8:e56819. [PMID: 23457620 DOI: 10.1371/journal.pone.0056819] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
8 Schiano C, Casamassimi A, Rienzo M, de Nigris F, Sommese L, Napoli C. Involvement of Mediator complex in malignancy. Biochim Biophys Acta 2014;1845:66-83. [PMID: 24342527 DOI: 10.1016/j.bbcan.2013.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
9 Pan M, Chiou Y, Chen L, Ho C. Breast cancer chemoprevention by dietary natural phenolic compounds: Specific epigenetic related molecular targets. Mol Nutr Food Res 2015;59:21-35. [DOI: 10.1002/mnfr.201400515] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
10 Berger E, Yorukoglu D, Zhang L, Nyquist SK, Shalek AK, Kellis M, Numanagić I, Berger B. Improved haplotype inference by exploiting long-range linking and allelic imbalance in RNA-seq datasets. Nat Commun 2020;11:4662. [PMID: 32938926 DOI: 10.1038/s41467-020-18320-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Li RH, Huang WH, Wu JD, Du CW, Zhang GJ. EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas. Oncol Lett 2017;13:695-703. [PMID: 28356948 DOI: 10.3892/ol.2016.5489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
12 Cho JG, Lim KH, Park SG. MED28 increases the colony-forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage. Oncol Lett 2018;15:3147-54. [PMID: 29435049 DOI: 10.3892/ol.2017.7718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Singh BN, Singh HB, Singh A, Naqvi AH, Singh BR. Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev 2014;33:41-85. [PMID: 24390421 DOI: 10.1007/s10555-013-9457-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
14 Gan W, Dang Y, Han X, Ling S, Duan J, Liu J, Xu J. ERK5/HDAC5-mediated, resveratrol-, and pterostilbene-induced expression of MnSOD in human endothelial cells. Mol Nutr Food Res 2016;60:266-77. [DOI: 10.1002/mnfr.201500466] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mocanu MM, Nagy P, Szöllősi J. Chemoprevention of Breast Cancer by Dietary Polyphenols. Molecules 2015;20:22578-620. [PMID: 26694341 DOI: 10.3390/molecules201219864] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
16 Deng L, Li Y, Zhang X, Chen B, Deng Y, Li Y. UPLC–MS method for quantification of pterostilbene and its application to comparative study of bioavailability and tissue distribution in normal and Lewis lung carcinoma bearing mice. Journal of Pharmaceutical and Biomedical Analysis 2015;114:200-7. [DOI: 10.1016/j.jpba.2015.04.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
17 Khajah MA, Al Saleh S, Mathew PM, Luqmani YA. Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells. PLoS One 2012;7:e41847. [PMID: 22860018 DOI: 10.1371/journal.pone.0041847] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
18 Lee M, Hsieh N, Huang C, Li C. All Trans -Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells: ALL TRANS -RETINOIC ACID, MED28, AND β-CATENIN SIGNALING. J Cell Physiol 2016;231:1796-803. [DOI: 10.1002/jcp.25285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Huang C, Chou Y, Hsieh N, Chen H, Lee M. MED28 regulates MEK1-dependent cellular migration in human breast cancer cells. J Cell Physiol 2012;227:3820-7. [DOI: 10.1002/jcp.24093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kadioglu O, Cao J, Saeed MEM, Greten HJ, Efferth T. Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals. Targ Oncol 2015;10:337-53. [DOI: 10.1007/s11523-014-0339-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
21 Huang C, Hsieh N, Pan M, Li C, Chou Y, Chiou Y, Lee M. Resveratrol and pterostilbene regulate MED28 (magicin/EG1) expression and cell growth in MCF7 human breast cancer cells. Journal of Functional Foods 2015;12:158-67. [DOI: 10.1016/j.jff.2014.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. J Nutr Biochem 2015;26:675-85. [PMID: 25792283 DOI: 10.1016/j.jnutbio.2015.01.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
23 Hsieh N, Huang C, Li C, Wang I, Lee M. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)‐dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells. J Cell Physiol 2019;234:11265-75. [DOI: 10.1002/jcp.27784] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
24 Yeh CB, Hsieh MJ, Lin CW, Chiou HL, Lin PY, Chen TY, Yang SF. The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation. PLoS One 2013;8:e56661. [PMID: 23437203 DOI: 10.1371/journal.pone.0056661] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
25 Joshi H, Vastrad B, Joshi N, Vastrad C, Tengli A, Kotturshetti I. Identification of Key Pathways and Genes in Obesity Using Bioinformatics Analysis and Molecular Docking Studies. Front Endocrinol (Lausanne) 2021;12:628907. [PMID: 34248836 DOI: 10.3389/fendo.2021.628907] [Reference Citation Analysis]
26 Tsai P, Hsieh C, Chiu C, Wang C, Chang L, Lin S. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway. Toxicon 2012;60:734-43. [DOI: 10.1016/j.toxicon.2012.05.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
27 Lee M, Lai C, Cheng A, Hou J, Badmaev V, Ho C, Pan M. Krill oil and xanthigen separately inhibit high fat diet induced obesity and hepatic triacylglycerol accumulation in mice. Journal of Functional Foods 2015;19:913-21. [DOI: 10.1016/j.jff.2014.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Enaru B, Socaci S, Farcas A, Socaciu C, Danciu C, Stanila A, Diaconeasa Z. Novel Delivery Systems of Polyphenols and Their Potential Health Benefits. Pharmaceuticals (Basel) 2021;14:946. [PMID: 34681170 DOI: 10.3390/ph14100946] [Reference Citation Analysis]
29 Varghese E, Samuel SM, Abotaleb M, Cheema S, Mamtani R, Büsselberg D. The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers. Cancers (Basel) 2018;10:E346. [PMID: 30248941 DOI: 10.3390/cancers10100346] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
30 Huang C, Hsieh N, Li C, Weng Y, Liu H, Lee M. MED28 Regulates Epithelial-Mesenchymal Transition Through NFκB in Human Breast Cancer Cells: MED28, EMT, AND BREAST CANCER. J Cell Physiol 2017;232:1337-45. [DOI: 10.1002/jcp.25610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
31 Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The Role of Resveratrol in Cancer Therapy. Int J Mol Sci 2017;18:E2589. [PMID: 29194365 DOI: 10.3390/ijms18122589] [Cited by in Crossref: 225] [Cited by in F6Publishing: 210] [Article Influence: 45.0] [Reference Citation Analysis]